Temporary Occlusion Micro Balloon Catheter for the Patient with Para…

Glen Schlaphoff

Chemo, Targeted and IO Treatment Options in Metastatic Renal Cell Ca…

Baltic and Eurasia Masterclass in Clinical Oncology

I. Tsimafeyeu

KU ASCO 2019 Updates: VEGF-TKI and/or PD-1/PD-L1 in Metastatic Renal…

KU Hematology & Medical Oncology Review 2019

R. Parikh

Role of Cytoreductive Nephrectomy in mRCC: Acceptable Morbidity Prof…

Fox Chase Updates in Bladder and Kidney Cancer 2019

S. Ginzburg

Kidney Cancer Panel Discussion: Controversies in Localized Disease, …

Fox Chase Updates in Bladder and Kidney Cancer 2019

R. Uzzo

Cryoablation & RF Ablation for Renal Tumors, Challenges and Pearls f…

Debra Ann Gervais

Renal Cell Carcinoma Year in Review

Symposium on Clinical Interventional Oncology (CIO 2018)

D. Gervais

Biliary Interventions in Hepatic Malignancies

Symposium on Clinical Interventional Oncology (CIO 2018)

K. Brown

Temporary Occlusion Micro Balloon Catheter: Do You Use the Device in…

Andrew Holden

G. Schlaphoff

SIR 2023: Percutaneous Cryoablation of 100 Anterior Renal Tumors - S…

SIR 2023 Conference Coverage

J. Raja

Spinal Tumor Ablation and Vertebral Augmentation for Treatment of Pa…

Douglas Beall

Multidisciplinary Approach to Hepatocellular Carcinoma

UCLA Health

G. Choi, B. Yanny, S. Sadeghi, J. Hui

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

Cryoablation - The Big Picture

Houston Methodist

D. Abdollahian

ESMO 2024 Summary: Updates in HCC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

H. Babiker

Expert Panel on TACE and TARE for HCC: Weighing the Pros and Cons

Integrity CE

M. Pishvaian, R. Salem